Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial
2012 ◽
Vol 379
(9835)
◽
pp. 2429-2438
◽
Edwin DeJesus
◽
Jürgen K Rockstroh
◽
Keith Henry
◽
Jean-Michel Molina
◽
Joseph Gathe
◽
...